CVR number 33767005
Industry 86.2300 Dental practice activities

Tandlægeselskabet Dentalklinikken INDRE BY ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.9% 1.7% 1.2% 1.3% 1.2%  
Credit score (0-100)  51 72 80 80 81  
Credit rating  BBB A A A A  
Credit limit (kDKK)  0.0 2.5 81.4 87.7 174.7  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Gross profit  5,903 6,343 6,558 7,937 8,198  
EBITDA  494 1,856 1,108 2,073 1,401  
EBIT  284 1,692 1,034 2,038 1,374  
Pre-tax profit (PTP)  273.2 1,672.6 1,033.4 2,028.8 1,376.6  
Net earnings  212.6 1,296.9 803.2 1,580.3 1,073.5  
Pre-tax profit without non-rec. items  273 1,673 1,033 2,029 1,377  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Tangible assets total  191 66.2 110 78.3 51.7  
Shareholders equity total  23.0 1,320 2,123 3,703 4,777  
Interest-bearing liabilities  1,604 574 504 504 504  
Balance sheet total (assets)  2,514 3,608 4,506 6,088 7,760  
Net Debt  1,537 454 453 410 448  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,903 6,343 6,558 7,937 8,198  
Gross profit growth  2.6% 7.4% 3.4% 21.0% 3.3%  
Employees  13 12 14 21 22  
Employee growth %  -7.1% -7.7% 16.7% 50.0% 4.8%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,514 3,608 4,506 6,088 7,760  
Balance sheet change%  -41.9% 43.5% 24.9% 35.1% 27.5%  
Added value  493.9 1,855.7 1,107.9 2,112.1 1,400.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -394 -327 -70 -70 -53  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  4.8% 26.7% 15.8% 25.7% 16.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.6% 55.6% 25.6% 38.5% 19.9%  
ROI %  12.2% 95.4% 45.5% 59.7% 29.0%  
ROE %  9.8% 193.1% 46.7% 54.2% 25.3%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  1.0% 41.7% 49.0% 63.3% 62.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  311.3% 24.5% 40.9% 19.8% 32.0%  
Gearing %  6,970.2% 43.5% 23.7% 13.6% 10.5%  
Net interest  0 0 0 0 0  
Financing costs %  1.1% 2.7% 0.8% 2.0% -0.2%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  1.0 2.4 2.2 3.5 3.0  
Current Ratio  0.9 1.9 2.0 3.1 2.8  
Cash and cash equivalent  66.8 120.1 50.9 93.4 55.7  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -265.2 1,581.3 2,180.2 4,001.7 4,956.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  38 155 79 101 64  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  38 155 79 99 64  
EBIT / employee  22 141 74 97 62  
Net earnings / employee  16 108 57 75 49